ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Egbert F. Smith, MD-PhD
The Netherlands Cancer Institute Amsterdam
Study Chair - Jürgen Wolf, MD-PhD
University Hospital Cologne
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Institut Jules Bordet
Brussels, Belgium
- St. James Hospital
Dublin, Ireland
- Irccs Instituto Tumori Giovanni Paolo Ii
Bari, Italy
- Instituto Europeo Di Oncologia (ieo)
Milan, Italy
- University Hospital of Turin
Turin, Italy
- Universita Di Verona
Verona, Italy
- the Netherlands Cancer Institute Amsterdam
Amsterdam, Netherlands
- University Medical Center Maastricht
Maastricht, Netherlands
- Hospital Teresa Herrara
A Coruña, Spain
- Hospital General de Alicante
Alicante, Spain
- Hospital Quirón Dexeus
Barcelona, Spain
- Hospital Sant Pau
Barcelona, Spain
- Vall D'Hebron University Hospital
Barcelona, Spain
- Hospital Puerta de Hierro
Madrid, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital Regional Universitario Carlos Haya
Málaga, Spain
- Hfr Fribourg
Fribourg, Switzerland
- Hôpital Universitaire de Genève
Geneva, Switzerland
- Universitatspital Zurich
Zurich, Switzerland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Nov 2018
- Primary completion
- 31 Mar 2021
- Completion
- 31 Mar 2021
- Last update posted
- 8 Apr 2025
- Registered enrollment
- 14
- Registry id
- NCT03445000
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.